222 related articles for article (PubMed ID: 17602247)
1. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.
Walji R; Boon H; Guns E; Oneschuk D; Younus J
Support Care Cancer; 2007 Aug; 15(8):913-21. PubMed ID: 17602247
[TBL] [Abstract][Full Text] [Related]
2. Black cohosh and breast cancer: a systematic review.
Fritz H; Seely D; McGowan J; Skidmore B; Fernandes R; Kennedy DA; Cooley K; Wong R; Sagar S; Balneaves LG; Fergusson D
Integr Cancer Ther; 2014 Jan; 13(1):12-29. PubMed ID: 23439657
[TBL] [Abstract][Full Text] [Related]
3. Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
McKenna DJ; Jones K; Humphrey S; Hughes K
Altern Ther Health Med; 2001; 7(3):93-100. PubMed ID: 11347288
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
[TBL] [Abstract][Full Text] [Related]
5. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".
Beer AM; Osmers R; Schnitker J; Bai W; Mueck AO; Meden H
Gynecol Endocrinol; 2013 Dec; 29(12):1022-5. PubMed ID: 23992293
[TBL] [Abstract][Full Text] [Related]
7. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).
Huntley A
Expert Opin Drug Saf; 2004 Nov; 3(6):615-23. PubMed ID: 15500420
[TBL] [Abstract][Full Text] [Related]
8. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy.
Borrelli F; Ernst E
Pharmacol Res; 2008 Jul; 58(1):8-14. PubMed ID: 18585461
[TBL] [Abstract][Full Text] [Related]
9. Black cohosh: an alternative therapy for menopause?
Mahady GB; Fabricant D; Chadwick LR; Dietz B
Nutr Clin Care; 2002; 5(6):283-9. PubMed ID: 12557811
[TBL] [Abstract][Full Text] [Related]
10. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events.
Borrelli F; Ernst E
Am J Obstet Gynecol; 2008 Nov; 199(5):455-66. PubMed ID: 18984078
[TBL] [Abstract][Full Text] [Related]
11. Effects of
Furtado Macruz C; Lima SMRR
J Obstet Gynaecol; 2022 Oct; 42(7):3236-3240. PubMed ID: 35993523
[TBL] [Abstract][Full Text] [Related]
12. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.
Gaube F; Wolfl S; Pusch L; Kroll TC; Hamburger M
BMC Pharmacol; 2007 Sep; 7():11. PubMed ID: 17880733
[TBL] [Abstract][Full Text] [Related]
14. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.
Burdette JE; Liu J; Chen SN; Fabricant DS; Piersen CE; Barker EL; Pezzuto JM; Mesecar A; Van Breemen RB; Farnsworth NR; Bolton JL
J Agric Food Chem; 2003 Sep; 51(19):5661-70. PubMed ID: 12952416
[TBL] [Abstract][Full Text] [Related]
15. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms.
Mahady GB
Treat Endocrinol; 2005; 4(3):177-84. PubMed ID: 15898823
[TBL] [Abstract][Full Text] [Related]
16. Black cohosh (black snakeroot, Cimicifuga racemosa (L.) Nutt., Actaea racemosa L.).
Barnes J
J Prim Health Care; 2010 Mar; 2(1):79-80. PubMed ID: 20690409
[No Abstract] [Full Text] [Related]
17. Benefit-risk profile of black cohosh (isopropanolic
Ruan X; Mueck AO; Beer AM; Naser B; Pickartz S
Climacteric; 2019 Aug; 22(4):339-347. PubMed ID: 30626212
[TBL] [Abstract][Full Text] [Related]
18. In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh).
Johnson BM; van Breemen RB
Chem Res Toxicol; 2003 Jul; 16(7):838-46. PubMed ID: 12870886
[TBL] [Abstract][Full Text] [Related]
19. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
Castelo-Branco C; Navarro C; Beltrán E; Losa F; Camacho M;
Gynecol Endocrinol; 2022 May; 38(5):379-384. PubMed ID: 35403534
[TBL] [Abstract][Full Text] [Related]
20. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.
Mahady GB; Low Dog T; Barrett ML; Chavez ML; Gardiner P; Ko R; Marles RJ; Pellicore LS; Giancaspro GI; Sarma DN
Menopause; 2008; 15(4 Pt 1):628-38. PubMed ID: 18340277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
